Trial Profile
A Phase II Study of Sunitinib Malate (Sutent) With Paclitaxel (Taxol) in Patients With Advanced Esophageal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary) ; Paclitaxel
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 16 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Sep 2008 New trial record.